The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis

BACKGROUND: Oral disease-modifying therapies offer equivalent or superior efficacy and greater convenience versus injectable options. OBJECTIVES: To compare patient-reported experiences of fingolimod and dimethyl fumarate. METHODS: Adult relapsing-remitting multiple sclerosis patients treated with f...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Res Notes
Main Authors: Wicks, Paul, Rasouliyan, Lawrence, Katic, Bo, Nafees, Beenish, Flood, Emuella, Sasané, Rahul
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5015319/
https://ncbi.nlm.nih.gov/pubmed/27604188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-016-2243-8
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki